Sepsis is currently defined as a life-threatening organ dysfunction caused by a dysregulated
host response to infection, and it affects over 25 million people every year. Even more …

Thymosin alpha 1 is a peptide naturally occurring in the thymus that has long been
recognized for modifying, enhancing, and restoring immune function. Thymosin alpha 1 has …

Emerged evidence has indicated that immunosuppression is involved in the occurrence and
development of sepsis. To provide clinical practice recommendations on the immune …

Thymosin α1 (Tα1) is an immunostimulatory peptide that is commonly used as an immune
enhancer in viral infectious diseases such as hepatitis B, hepatitis C, and acquired immune …

Introduction Severe sepsis is associated with a high mortality rate despite implementation of
guideline recommendations. Adjunctive treatment may be efficient and require further …

COVID-19 is known for its magical infectivity, fast transmission and high death toll based on
the large number of infected people. From the perspective of the clinical manifestation …

Background COVID-19 characterized by refractory hypoxemia increases patient mortality
because of immunosuppression effects. This study aimed to evaluate the efficacy of …

Abstract Thymosin alpha 1 (Ta1) is a peptide originally isolated from thymic tissue as the
compound responsible for restoring immune function to thymectomized mice. Ta1 has a …

The peculiar property of Thymosin alpha 1 (Tα1) to act as master regulator of immune
homeostasis has been successfully defined in different physiological and pathological …

Intestinal inflammatory disorders, such as inflammatory bowel disease (IBD), are associated
with increased pro-inflammatory cytokine secretion in the intestines. Furthermore, intestinal …